NKX3-1 and posterior cortical atrophy: This is further confirmed by the observation that modulating ELOVL5 expression in C4-2 by either CRISPR-Cas9 knocking out or overexpressing led to the opposite change of NSE and NKX3.1 expression, two markers representing neuroendocrine PCa and luminal PCa cells, respectively (Figure 3C).